Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Generic terfenadine approved for U.S. marketing

Jan. 10, 1997

Merck Frosst discloses leukotriene biosynthesis inhibitors

Jan. 10, 1997

New IL-4 antagonist from Hoechst

Jan. 10, 1997

ICOS-Suntory j.v. to develop rPAF-AH

Jan. 9, 1997

Nasalcrom cleared by FDA as OTC

Jan. 8, 1997

Zeneca describes nonpeptide antagonists of NK2 receptors

Jan. 8, 1997

Improved formulation of Vanceril approved for market

Jan. 7, 1997

Genome Therapeutics and Schering-Plough genomic-based collaboration

Dec. 31, 1996

Heterocyclic tachykinin antagonists revealed by Zeneca

Dec. 31, 1996

New NK1 antagonists from Ciba-Geigy

Dec. 31, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Sept. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Sept. 18, 2025.
The ‘molecular revolution’ driving R&D of new cancer therapeutics
BioWorld Asia
“New explosions in biotechnology are allowing us to interrogate cancers at a very sophisticated level compared to before,” Dennis Slamon told audience members at...
Remynd’s REM-127 yields positive phase II data in Alzheimer’s
BioWorld
Remynd NV has turned in positive phase IIa data for a new target in Alzheimer’s disease, showing that restoring calcium homeostasis in neurons reduces levels of...
The domino effect of cutting mRNA vaccine research
BioWorld
In August, a press release from HHS announced the cancellation of 22 vaccine research projects based on mRNA, the latest available technology aimed at developing...